The recall, which is still ongoing, affects more than 41,000 bottles across two Proactiv-branded acne treatment products.

The medication's acne-fighting benefits have been backed by science for decades, but it’s important to be aware of a few serious risks.

A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...